ES2165232T3 - Sistema terapeutico transdermico (tts) que contiene oxibutinina. - Google Patents
Sistema terapeutico transdermico (tts) que contiene oxibutinina.Info
- Publication number
- ES2165232T3 ES2165232T3 ES99913259T ES99913259T ES2165232T3 ES 2165232 T3 ES2165232 T3 ES 2165232T3 ES 99913259 T ES99913259 T ES 99913259T ES 99913259 T ES99913259 T ES 99913259T ES 2165232 T3 ES2165232 T3 ES 2165232T3
- Authority
- ES
- Spain
- Prior art keywords
- tts
- therapeutic system
- transdermal therapeutic
- oxybutynin
- oxibutinine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Abstract
Sistema terapéutico transdérmico (TTS) para la administración por vía transcutánea de oxibutinina a lo largo de varios días, estando caracterizado el TTS porque contiene una masa de matriz en forma estratificada, autoadhesiva, con un contenido de oxibutinina, que consta de un copolímero de (met)acrilato que contiene grupos de amonio, por lo menos de un triéster de ácido cítrico y de 5 25 % en peso de oxibutinina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19812413A DE19812413C1 (de) | 1998-03-20 | 1998-03-20 | Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2165232T3 true ES2165232T3 (es) | 2002-03-01 |
Family
ID=7861773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99913259T Expired - Lifetime ES2165232T3 (es) | 1998-03-20 | 1999-03-16 | Sistema terapeutico transdermico (tts) que contiene oxibutinina. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6555129B1 (es) |
EP (1) | EP1063983B1 (es) |
JP (1) | JP2002507565A (es) |
KR (1) | KR100561961B1 (es) |
CN (1) | CN1134254C (es) |
AT (1) | ATE209912T1 (es) |
AU (1) | AU745923B2 (es) |
BR (1) | BR9908910A (es) |
CA (1) | CA2311354C (es) |
DE (3) | DE29823343U1 (es) |
DK (1) | DK1063983T3 (es) |
ES (1) | ES2165232T3 (es) |
HK (1) | HK1035864A1 (es) |
IL (1) | IL135306A (es) |
MX (1) | MXPA00009231A (es) |
NZ (1) | NZ504038A (es) |
PT (1) | PT1063983E (es) |
WO (1) | WO1999048493A1 (es) |
ZA (1) | ZA992130B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6436428B1 (en) * | 2000-03-21 | 2002-08-20 | Enhance Pharmaceuticals, Inc. | Device and method for treating urinary incontinence in females |
US7179483B2 (en) * | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
US7029694B2 (en) | 2000-04-26 | 2006-04-18 | Watson Laboratories, Inc. | Compositions and methods for transdermal oxybutynin therapy |
CN1438861A (zh) * | 2000-04-26 | 2003-08-27 | 沃特森药物公司 | 最小化与奥昔布宁疗法有关的副作用 |
DE10033855A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers |
DE10060550C1 (de) * | 2000-12-06 | 2002-04-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten |
ITMI20020798A1 (it) * | 2002-04-15 | 2003-10-15 | F T Holding S A | Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici |
US20050058688A1 (en) * | 2003-02-22 | 2005-03-17 | Lars Boerger | Device for the treatment and prevention of disease, and methods related thereto |
DE10315878B4 (de) * | 2003-04-08 | 2009-06-04 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung |
TW200512013A (en) * | 2003-09-18 | 2005-04-01 | Orient Europharma Co Ltd | Gel formulation of oxybutynin hydrochloride |
CN102309447A (zh) * | 2010-07-06 | 2012-01-11 | 上海现代药物制剂工程研究中心有限公司 | 含盐酸奥昔布宁的自粘性喷雾透皮组合物及制备方法 |
EP2658576A1 (en) * | 2010-12-29 | 2013-11-06 | Pharmafilm S.R.L. | Medicated patch for improved transdermal permeation of diclofenac diethylammonium |
CN103919754B (zh) * | 2013-01-15 | 2018-11-06 | 江苏康倍得药业股份有限公司 | 奥昔布宁药物组合物及其应用 |
CA2973372A1 (en) | 2015-01-09 | 2016-07-14 | Chase Pharmaceuticals Corporation | Oxybutynin transdermal therapeutic system combination |
CN108498491A (zh) * | 2018-06-26 | 2018-09-07 | 沈阳药科大学 | 一种奥昔布宁经皮吸收贴剂及其制备和应用 |
CN113143891B (zh) * | 2021-04-27 | 2022-05-03 | 杭州仁德医药有限公司 | 一种奥昔布宁透皮贴膏及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6139868A (en) * | 1986-08-28 | 2000-10-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
JP3136413B2 (ja) | 1991-02-22 | 2001-02-19 | リードケミカル株式会社 | 経皮吸収型頻尿・尿失禁治療剤 |
DE4310012A1 (de) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
US5747065A (en) * | 1993-09-29 | 1998-05-05 | Lee; Eun Soo | Monoglyceride/lactate ester permeation enhancer for oxybutynin |
US5601839A (en) * | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
PL329196A1 (en) * | 1996-03-25 | 1999-03-15 | Lohmann Therapie Syst Lts | Transdermal therapeutic system of small thickness and high elasticity and methos of obtaining such system |
DE19653605C2 (de) * | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
DE19653606A1 (de) * | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher |
-
1998
- 1998-03-20 DE DE29823343U patent/DE29823343U1/de not_active Expired - Lifetime
- 1998-03-20 DE DE19812413A patent/DE19812413C1/de not_active Expired - Fee Related
-
1999
- 1999-03-16 DK DK99913259T patent/DK1063983T3/da active
- 1999-03-16 ES ES99913259T patent/ES2165232T3/es not_active Expired - Lifetime
- 1999-03-16 WO PCT/EP1999/001707 patent/WO1999048493A1/de active IP Right Grant
- 1999-03-16 PT PT99913259T patent/PT1063983E/pt unknown
- 1999-03-16 AT AT99913259T patent/ATE209912T1/de not_active IP Right Cessation
- 1999-03-16 NZ NZ504038A patent/NZ504038A/en unknown
- 1999-03-16 AU AU31452/99A patent/AU745923B2/en not_active Ceased
- 1999-03-16 US US09/622,848 patent/US6555129B1/en not_active Expired - Fee Related
- 1999-03-16 KR KR1020007004724A patent/KR100561961B1/ko not_active IP Right Cessation
- 1999-03-16 BR BR9908910-6A patent/BR9908910A/pt not_active IP Right Cessation
- 1999-03-16 MX MXPA00009231A patent/MXPA00009231A/es unknown
- 1999-03-16 CN CNB998022632A patent/CN1134254C/zh not_active Expired - Fee Related
- 1999-03-16 DE DE59900497T patent/DE59900497D1/de not_active Expired - Fee Related
- 1999-03-16 IL IL13530699A patent/IL135306A/xx not_active IP Right Cessation
- 1999-03-16 EP EP99913259A patent/EP1063983B1/de not_active Expired - Lifetime
- 1999-03-16 CA CA002311354A patent/CA2311354C/en not_active Expired - Fee Related
- 1999-03-16 JP JP2000537541A patent/JP2002507565A/ja active Pending
- 1999-03-17 ZA ZA9902130A patent/ZA992130B/xx unknown
-
2001
- 2001-09-14 HK HK01106522A patent/HK1035864A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1063983A1 (de) | 2001-01-03 |
IL135306A0 (en) | 2001-05-20 |
IL135306A (en) | 2005-06-19 |
BR9908910A (pt) | 2000-11-21 |
DE19812413C1 (de) | 1999-06-10 |
CA2311354A1 (en) | 1999-09-30 |
ZA992130B (en) | 1999-09-17 |
HK1035864A1 (en) | 2001-12-14 |
MXPA00009231A (es) | 2002-06-04 |
AU3145299A (en) | 1999-10-18 |
PT1063983E (pt) | 2002-05-31 |
DK1063983T3 (da) | 2002-01-07 |
NZ504038A (en) | 2001-09-28 |
CA2311354C (en) | 2004-08-10 |
CN1134254C (zh) | 2004-01-14 |
AU745923B2 (en) | 2002-04-11 |
DE59900497D1 (de) | 2002-01-17 |
KR20010031668A (ko) | 2001-04-16 |
US6555129B1 (en) | 2003-04-29 |
JP2002507565A (ja) | 2002-03-12 |
WO1999048493A1 (de) | 1999-09-30 |
ATE209912T1 (de) | 2001-12-15 |
CN1288376A (zh) | 2001-03-21 |
KR100561961B1 (ko) | 2006-03-21 |
DE29823343U1 (de) | 1999-07-15 |
EP1063983B1 (de) | 2001-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0010618A (pt) | Sistema terapêutico transdermal (tts), que contém tolterodina | |
ES2165232T3 (es) | Sistema terapeutico transdermico (tts) que contiene oxibutinina. | |
ES2167116T3 (es) | Sistema terapeutico transdermico (tts) que contiene pergolida. | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
NZ306249A (en) | matrix patch containing triacetin as a transdermal pentration enhancer | |
DE50212267D1 (de) | Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung | |
DE59308413D1 (de) | Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung | |
DK1383540T3 (da) | Fremgangsmdåer og farmaceutiske sammensætninger til sårheling | |
AU2108300A (en) | Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids | |
KR880010765A (ko) | 니트로글리세린의 경피 투여형 약제 | |
MD937C2 (ro) | Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui | |
DK1296662T3 (da) | Dermalt terapeutisk system indeholdende 2-(3-benzophenyl)-propionsyre eller [o-(2,6-dichloranilino)-phenyl]-eddikesyre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 1063983 Country of ref document: ES |